title: Renal vascular response to interruption of the renin-angiotensin system in normal man.
abstract: We assessed the role of the renin-angiotensin system in the response of the renal circulation to restriction of sodium intake in 38 normal patients. Both saralasin (10 to 30 ng/kg/min), an angiotensin antagonist, and SQ 20881 (30 to 300microgram/kg), a converting enzyme inhibitor, induced a dose-related increase in renal blood flow (xenon 133 washout) only when the resin-angiotension system was activated by restriction of sodium intake to 10 MEq/day. Increasing doses of saralasin (100 to 1,000 ng/kg/min) reduced renal blood flow, presumably due to the angiotensin-like action of this partial agonist. The renal vascular response to SQ 20881 paralleled the endocrine response: An identical threshold dose (30 microgram/kg) increased renal blood flow and reduced plasma angiotensin II concentration, which fell despite a progressive rise of plasma renin activity. Plasma bradykinin concentration did not change in response to SQ 20881, which also blocks kininase II. Both agents also induced a small but consistent and statistically significant reduction in arterial blood pressure, which will be important in assessing the pathogenetic significance of a blood pressure reduction in patients with hypertension. This study indicates that angiotensin mediates the renal vascular response to restriction of salt intake in normal man and provides an approach to assessing the role played by angiotensin in the pathogenesis of functional renal disease.
mesh_terms: D000293:Adolescent; D000328:Adult; D000804:Angiotensin II / Q000031:analogs & derivatives* / Q000097:blood*; D000809:Angiotensins / Q000037:antagonists & inhibitors; D001794:Blood Pressure / Q000187:drug effects*; D006801:Humans; D007668:Kidney / Q000098:blood supply* / Q000187:drug effects; D008875:Middle Aged; D012083:Renin / Q000097:blood*; D012504:Saralasin / Q000494:pharmacology*; D012964:Sodium / Q000652:urine; D013722:Teprotide / Q000494:pharmacology
chemical_list: D000809:Angiotensins; D000804:Angiotensin II; D012964:Sodium; D013722:Teprotide; D012083:Renin; D012504:Saralasin